Alnylam shareholders approve officer exculpation charter amendment, re-elect four directors

ALNYLAM PHARMACEUTICALS, INC.

Filed certificate of amendment to allow officer exculpation; approved with 111.5M for, 7.1M against.
Re-elected four Class III directors (Carolyn Bertozzi, Margaret Hamburg, Colleen Reitan, Amy Schulman) with majority support.
Approved Second Amended and Restated 2018 Stock Incentive Plan (114.0M for, 4.6M against).
Non-binding advisory vote on executive compensation passed (111.7M for, 6.9M against).
Ratified PwC as independent auditors for FY2025 (117.0M for, 6.4M against).

item 5.03 item 5.07 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ALNYLAM PHARMACEUTICALS, INC.: Certificate of Amendment filed to allow for officer exculpation (effective 2025-05-08).

Change: charter amendment
Effective: 2025-05-08

Exact text from the filing

the Company filed a Certificate of Amendment to the Company’s Restated Certificate of Incorporation to allow for officer exculpation (the “Certificate of Amendment”).

View on SEC.gov

Browse all governance changes →

ALNYLAM PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001178670-25-000062

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.